Skip to contentB
Bausch Health Companies Inc.
B
BHCBausch Health Companies Inc. Q1 2022 · 10-Q
Revenue$1.92B$1.92B−5.4% vs Q1 2021 Net Income-$69.00M-$69.00MN/M vs Q1 2021 EPS Diluted-$0.19-$0.19N/M vs Q1 2021 Operating Income$285,000,000N/M Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Bausch Health Companies Inc. · CIK 885590 · Engraved from SEC EDGAR
Free Cash Flowderived-$109,000,000N/M Margins · derivedOperating margin14.9%+25.8 pt vs Q1 2021
Net margin-3.6%+26.5 pt vs Q1 2021
ended Mar 31, 2022 · filed May 10, 2022 · 40 d after period end